Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Dual Role of HLA-G in Cancer
Nathalie Rouas‐Freiss, Philippe Moreau, Joël LeMaoult, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 276
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
Edgardo D. Carosella, Guillaume Ploussard, Joël LeMaoult, et al.
European Urology (2015) Vol. 68, Iss. 2, pp. 267-279
Closed Access | Times Cited: 213
Individual response to ionizing radiation
Nicolas Foray, Michel Bourguignon, Nobuyuki Hamada
Mutation Research/Reviews in Mutation Research (2016) Vol. 770, pp. 369-386
Closed Access | Times Cited: 159
Immune signature of tumor infiltrating immune cells in renal cancer
Klaus Geißler, Paolo Fornara, Christine Lautenschläger, et al.
OncoImmunology (2015) Vol. 4, Iss. 1, pp. e985082-e985082
Open Access | Times Cited: 155
Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 121
HLA and proteasome expression body map
Sebastian Boegel, Martin Löwer, Thomas Bukur, et al.
BMC Medical Genomics (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 100
Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
Adrià Archilla‐Ortega, Carla Domuro, Juan Martín-Liberal, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 63
HLA‐G promotes myeloid‐derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4
Natascha Köstlin, Anna‐Lena Ostermeir, Bärbel Spring, et al.
European Journal of Immunology (2016) Vol. 47, Iss. 2, pp. 374-384
Open Access | Times Cited: 82
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma
Simon Jasinski‐Bergner, Robert Stoehr, Juergen Bukur, et al.
OncoImmunology (2015) Vol. 4, Iss. 6, pp. e1008805-e1008805
Open Access | Times Cited: 70
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
Emilia Andersson, Isabel Poschke, Lisa Villabona, et al.
OncoImmunology (2015) Vol. 5, Iss. 1, pp. e1052213-e1052213
Open Access | Times Cited: 66
HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Human Radiosensitivity and Radiosusceptibility: What Are the Differences?
Laura El Nachef, Joëlle Al-Choboq, Juliette Restier-Verlet, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7158-7158
Open Access | Times Cited: 51
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
Human leukocyte immunoglobulin-like receptors in health and disease
Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
HLA‐G: Function, polymorphisms and pathology
Antonio Arnaiz‐Villena, Ignacio Juárez, Fabio Suárez‐Trujillo, et al.
International Journal of Immunogenetics (2020) Vol. 48, Iss. 2, pp. 172-192
Open Access | Times Cited: 49
Immunoglobulin‑like transcript 4 and human leukocyte antigen‑G interaction promotes the progression of human colorectal cancer
Zhaoyang Cai, Lu Wang, Yali Han, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 44
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Jiji V. D. Attia, Charlotte E. Dessens, Ricky B. van de Water, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8678-8678
Open Access | Times Cited: 40
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
Farhoodeh Ghaedrahmati, Nafiseh Esmaeil, Maryam Abbaspour
Cancer Communications (2022) Vol. 43, Iss. 2, pp. 177-213
Open Access | Times Cited: 23
Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer
Rui Wan, Ziwei Wang, Hui Li, et al.
Cellular Physiology and Biochemistry (2017) Vol. 44, Iss. 5, pp. 1828-1841
Open Access | Times Cited: 47
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
Simon Jasinski‐Bergner, Adi Reches, Robert Stoehr, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 26866-26878
Open Access | Times Cited: 45
HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases
Marloes Swets, Marion König, Anniek Zaalberg, et al.
Human Immunology (2016) Vol. 77, Iss. 9, pp. 773-779
Closed Access | Times Cited: 42
The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells
Lu Liu, Lijun Wang, Lihong Zhao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 37
The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy
Lidy Vannessa Mejía-Guarnizo, Paula Stefany Monroy-Camacho, Andrés David Turizo-Smith, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top